Children's Hospital Colorado
129
29
44
60
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.8%
10 terminated/withdrawn out of 129 trials
85.7%
-0.8% vs industry average
7%
9 trials in Phase 3/4
32%
19 of 60 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (129)
Adapting a Psychosocial Support Intervention for the Rett Syndrome Community
Role: collaborator
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Role: collaborator
Parent Management Training to Treat Irritability
Role: collaborator
Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial
Role: collaborator
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Role: collaborator
The Treatment of Type I Open Fractures in Pediatrics
Role: collaborator
Rett Syndrome Registry
Role: collaborator
Impact of Dental Desensitization Facilitated by a Child Life Specialist Distress and Cooperation
Role: lead
Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
Role: collaborator
Advanced SPinal Innovations With Robotics and Enabling Technology Registry
Role: collaborator
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Role: collaborator
Cerebral Palsy Adult Transition Longitudinal Study
Role: collaborator
Osteochondritis Dissecans of Knee Prospective Cohort
Role: collaborator
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Role: collaborator
Sinus Disease in Young Children With Cystic Fibrosis
Role: collaborator
Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum
Role: collaborator
Liver Disease in Urea Cycle Disorders
Role: collaborator
24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
Role: collaborator
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Role: collaborator
24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs
Role: collaborator